Superficial dermatomycoses worldwide: multinational treatment experience with a combination of isoconazole nitrate and diflucortolone valerate. Introduction.
Czaika
Viktor A
VA
Dermatology Out-patient Department of Internal Medicine, Helios Clinic Bad Saarow, Bad Saarow, Germany. viktor.czaika@gmx.de
D000279:Administration, Cutaneous; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy* / Q000453:epidemiology*; D004060:Diflucortolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D014943:Global Health; D006801:Humans; D038622:Internationality; D008825:Miconazole / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D014005:Tinea / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D004338:Drug Combinations; C013486:diflucortolone valerate; C020531:Travocort; D008825:Miconazole; C020382:isoconazole; D004060:Diflucortolone